Market share and costs of biologic therapies for inflammatory bowel disease in the USA
Market share and costs of biologic therapies for inflammatory bowel disease in the USA is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Market share and costs of biologic therapies for inflammatory bowel disease in the USA have?
Market share and costs of biologic therapies for inflammatory bowel disease in the USA has 181 citations in the OpenAlex counts ScholarIQ stores.
When was Market share and costs of biologic therapies for inflammatory bowel disease in the USA published?
Market share and costs of biologic therapies for inflammatory bowel disease in the USA has 2017 year in the ScholarIQ index.
What is the open-access status of Market share and costs of biologic therapies for inflammatory bowel disease in the USA?
Market share and costs of biologic therapies for inflammatory bowel disease in the USA has bronze oa status in the ScholarIQ index.
What is the DOI of Market share and costs of biologic therapies for inflammatory bowel disease in the USA?
The DOI for Market share and costs of biologic therapies for inflammatory bowel disease in the USA is on the source record.
What is the PMID of Market share and costs of biologic therapies for inflammatory bowel disease in the USA?
The PMID for Market share and costs of biologic therapies for inflammatory bowel disease in the USA is on the source record.
What is the OpenAlex record for Market share and costs of biologic therapies for inflammatory bowel disease in the USA?
The OpenAlex for Market share and costs of biologic therapies for inflammatory bowel disease in the USA is on the source record.